Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users

By Loughlin A.   Metsch L.   Gardner L.   Anderson-mahoney P.   Barrigan M.   Strathdee S.  

AIDS Care, Vol. 16, Iss. 4, 2004-05 ,pp. : 485-500

Routledge Ltd

Access to resources Recommend Favorite

Partner notification with HIV-infected drug users: results of formative research

By Rogers S. J.   Tross S.   Doino-Ingersol J.   Weisfuse I.  

AIDS Care, Vol. 10, Iss. 4, 1998-08 ,pp. : 415-429

Routledge Ltd

Access to resources Recommend Favorite

CMV pp65 antigen testing is of limited utility in the diagnosis of concomitant CMV disease in HIV-infected patients in the HAART era

By Skiest D.J.   Crosby C.  

Journal of Clinical Virology, Vol. 28, Iss. 2, 2003-10 ,pp. : 203-213

Elsevier

Access to resources Recommend Favorite

HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use

By Chander Geetanjali   Himelhoch Seth   Fleishman John   Hellinger James   Gaist Paul   Moore Richard   Gebo Kelly  

AIDS Care, Vol. 21, Iss. 5, 2009-05 ,pp. : 655-663

Routledge Ltd

Access to resources Recommend Favorite

Sexual risk behaviors among HIV-infected South Indian couples in the HAART era: implications for reproductive health and HIV care delivery

By Venkatesh Kartik   Srikrishnan A. K.   Safren Steven   Triche Elizabeth   Thamburaj E.   Prasad Lakshmi   Lurie Mark   Kumar M. Suresh   Kumarasamy N.   Solomon Suniti   Mayer Kenneth  

AIDS Care, Vol. 23, Iss. 6, 2011-06 ,pp. : 722-733

Routledge Ltd

Access to resources Recommend Favorite